Form 8-K - Current report:
SEC Accession No. 0001193125-12-231281
Filing Date
2012-05-14
Accepted
2012-05-14 16:05:43
Documents
3
Period of Report
2012-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d354718d8k.htm 8-K 16521
2 PRESS RELEASE d354718dex991.htm EX-99.1 55339
3 GRAPHIC g354718ex99_1-pg001.jpg GRAPHIC 9830
  Complete submission text file 0001193125-12-231281.txt   86974
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 12838726
SIC: 2834 Pharmaceutical Preparations